Literature DB >> 19802576

Subversion of interferon by dengue virus.

Jorge L Muñoz-Jordán1.   

Abstract

Dengue virus is sensed in mammalian cells by Toll-like receptors and DExD/H box RNA helicases, triggering a Type 1 interferon response. Interferon acts upon infected and noninfected cells by stimulating the JAK/STAT signaling pathway resulting in the activation of interferon stimulated genes that lead cells toward the establishment of an antiviral response. The recognition of the importance of this rapid protective response should come with the realization that dengue virus would circumvent the interferon response to propagate in the host. There is recent, mounting evidence for mechanisms encoded by the dengue virus that weaken interferon signaling. Nonstructural proteins expressed separately or in replicon vectors block phosphorylation and down-regulate expression of major components of the JAK/STAT pathway, causing reduced activation of gene expression in response to IFNalpha/beta interferon. As our understanding of viral-host interaction increases, opportunities for improved biological models and therapeutics discovery arise.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19802576     DOI: 10.1007/978-3-642-02215-9_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  20 in total

1.  Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines.

Authors:  James F Kelley; Pakieli H Kaufusi; Esther M Volper; Vivek R Nerurkar
Journal:  Virology       Date:  2011-08-02       Impact factor: 3.616

2.  Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon interaction.

Authors:  Yesseinia I Angleró-Rodríguez; Petraleigh Pantoja; Carlos A Sariol
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

3.  Chemoproteomic profiling identifies changes in DNA-PK as markers of early dengue virus infection.

Authors:  Michael L Vetter; Mary A Rodgers; Matthew P Patricelli; Priscilla L Yang
Journal:  ACS Chem Biol       Date:  2012-10-02       Impact factor: 5.100

Review 4.  Host-Virus Interaction of ZIKA Virus in Modulating Disease Pathogenesis.

Authors:  Nanda Kishore Routhu; Siddappa N Byrareddy
Journal:  J Neuroimmune Pharmacol       Date:  2017-03-27       Impact factor: 4.147

5.  Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock.

Authors:  Penny A Rudd; Jane Wilson; Joy Gardner; Thibaut Larcher; Candice Babarit; Thuy T Le; Itaru Anraku; Yutaro Kumagai; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Alexander A Khromykh; Andreas Suhrbier
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

6.  Delayed cytosolic exposure of Japanese encephalitis virus double-stranded RNA impedes interferon activation and enhances viral dissemination in porcine cells.

Authors:  Lyre Anni Espada-Murao; Kouichi Morita
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

7.  Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex.

Authors:  Juan R Rodriguez-Madoz; Alan Belicha-Villanueva; Dabeiba Bernal-Rubio; Joseph Ashour; Juan Ayllon; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

8.  Dengue virus inhibits the production of type I interferon in primary human dendritic cells.

Authors:  Juan R Rodriguez-Madoz; Dabeiba Bernal-Rubio; Dorota Kaminski; Kelley Boyd; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

9.  Classification of dengue fever patients based on gene expression data using support vector machines.

Authors:  Ana Lisa V Gomes; Lawrence J K Wee; Asif M Khan; Laura H V G Gil; Ernesto T A Marques; Carlos E Calzavara-Silva; Tin Wee Tan
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

Review 10.  Dengue virus infection: current concepts in immune mechanisms and lessons from murine models.

Authors:  Rodrigo Guabiraba; Bernhard Ryffel
Journal:  Immunology       Date:  2014-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.